Page last updated: 2024-09-02

thromboxanes and Hypersensitivity, Type III

thromboxanes has been researched along with Hypersensitivity, Type III in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Emancipator, SN; Lamm, ME1
Ito, Y; Ooi, BS; Pollak, VE; Weiss, MA; Yamashita, W1

Reviews

1 review(s) available for thromboxanes and Hypersensitivity, Type III

ArticleYear
Pathways of tissue injury initiated by humoral immune mechanisms.
    Laboratory investigation; a journal of technical methods and pathology, 1986, Volume: 54, Issue:5

    Topics: Animals; Complement Activation; Complement C3; Complement C5; Free Radicals; Immune Complex Diseases; Immunoglobulin A; Immunoglobulin G; Inflammation; Leukocytes; Lung Diseases; Oxygen; Prostaglandins; SRS-A; Thromboxanes; Vasomotor System

1986

Other Studies

1 other study(ies) available for thromboxanes and Hypersensitivity, Type III

ArticleYear
A thromboxane synthetase antagonist ameliorates progressive renal disease of Dahl-S rats.
    Kidney international, 1988, Volume: 33, Issue:1

    Topics: Acrylates; Animals; Creatinine; Fatty Acids, Unsaturated; Immune Complex Diseases; In Vitro Techniques; Kidney Glomerulus; Male; Methacrylates; Nephritis; Proteinuria; Rats; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes

1988